Magdalena M. Gorska

Magdalena M. Gorska

Auto-generated profile, based on publicly available information

Magdalena M. Gorska

Division of Allergy and Clinical Immunology, Department of Medicine, National Jewish Health, Denver, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
SMSarah Manners
Sarah Manners
RARafeul Alam
Rafeul Alam
DSDavid A. Schwartz
David A. Schwartz
MGMagdalena M. Gorska
Magdalena M. Gorska

2 June 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MVMukesh Verma
Mukesh Verma
LMLidia Michalec
Lidia Michalec
ASAnand Sripada
Anand Sripada
JMJerome McKay
Jerome McKay
KSKapil Sirohi
Kapil Sirohi
RARafeul Alam
Rafeul Alam
Repetitive exposure of Rag1−/− mice to the Alternaria allergen extract generated a form of memory that elicited an asthma-like response upon a subthreshold recall challenge 3–15 wk later. This memory was associated with lung ICOS+ST2+ ILC2s. Genetic, pharmacologic, and antibody-mediated inhibition and adoptive transfer established an essential role for ILC2s in memory-driven asthma. ATAC-seq demonstrated a distinct epigenetic landscape of memory ILC2s and identified Bach2 and AP1 (JunD and Fosl2) motifs as major drivers of altered gene accessibility. scRNA-seq, gene knockout, and signaling studies suggest that repetitive allergenic stress induces a gene repression program involving Nr4a2, Zeb1, Bach2, and JunD and a preparedness program involving Fhl2, FosB, Stat6, Srebf2, and MPP7 in memory ILC2s. A mutually regulated balance between these two programs establishes and maintains memory. The preparedness program (e.g., Fhl2) can be activated with a subthreshold cognate stimulation, which down-regulates repressors and activates effector pathways to elicit the memory-driven phenotype.

1 February 2017 in Current Opinion in Allergy and Clinical Immunology
Verified
Journal Article
Closed access
MGMagdalena M. Gorska
Magdalena M. Gorska
Purpose of review: This review article discusses current knowledge on natural killer (NK) cells in asthma. Recent findings: It is now well accepted that NK cell activities go beyond cancer immune surveillance and antiviral defense. Recent reports indicate that NK cells are activated in response to allergens in vivo. NK cells promote allergic sensitization, type-2 immune response, development of eosinophilic inflammation, and airway hyperresponsiveness. NK cells are activated by respiratory syncytial virus and other respiratory viruses. When infection occurs in the setting of active allergic inflammation, NK cells augment its magnitude and contribute to asthma exacerbations. Proasthma activities of NK cells can be programmed during embryogenesis through maternal exposure to environmental pollutants. Prenatally programmed NK cells produce type-2 and type-3 cytokines and mediate asthma predisposition. NK cells can also act as asthma antagonists. NK cells contribute to the resolution of inflammation through suppression of antigen-specific CD4+ T cells and type-3 immunity. When viral infection occurs in naïve mice prior to allergic sensitization, NK cells antagonize type-2 immunity and prevent development of asthma. Summary: NK cells are nonredundant participants of allergic inflammation. The environmental context determines whether NK cells act as protagonists or antagonists.

3 August 2020 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
QQQian Qian
Qian Qian
BCBidisha Paul Chowdhury
Bidisha Paul Chowdhury
ZSZehua Sun
Zehua Sun
JLJerica Lenberg
Jerica Lenberg
RARafeul Alam
Rafeul Alam
MGMagdalena M. Gorska
Magdalena M. Gorska
Mothers living near high-traffic roads before or during pregnancy are more likely to have children with asthma. Mechanisms are unknown. Using a mouse model, here we showed that maternal exposure to diesel exhaust particles (DEP) predisposed offspring to allergic airway disease (AAD, murine counterpart of human asthma) through programming of their NK cells; predisposition to AAD did not develop in DEP pups that lacked NK cells and was induced in normal pups receiving NK cells from WT DEP pups. DEP NK cells expressed GATA3 and cosecreted IL-13 and the killer protease granzyme B in response to allergen challenge. Extracellular granzyme B did not kill, but instead stimulated protease-activated receptor 2 (PAR2) to cooperate with IL-13 in the induction of IL-25 in airway epithelial cells. Through loss-of-function and reconstitution experiments in pups, we showed that NK cells and granzyme B were required for IL-25 induction and activation of the type 2 immune response and that IL-25 mediated NK cell effects on type 2 response and AAD. Finally, experiments using human cord blood and airway epithelial cells suggested that DEP might induce an identical pathway in humans. Collectively, we describe an NK cell–dependent endotype of AAD that emerged in early life as a result of maternal exposure to DEP.

10 July 2018
Verified
Book Chapter
Closed access
PDF file
MGMagdalena M. Gorska
Magdalena M. Gorska

23 June 2012 in Current Allergy and Asthma Reports
Verified
Journal Article
Closed access
PDF file
MGMagdalena M. Gorska
Magdalena M. Gorska
RARafeul Alam
Rafeul Alam